← Back to Clinical Trials
Recruiting NCT07240571

NCT07240571 Randomized Controlled Trial of a Family-focused Intervention for Caregivers and Young Adolescents (Phase 3 of FLOURISH)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07240571
Status Recruiting
Phase
Sponsor University of Klagenfurt
Condition Adolescent - Emotional Problem
Study Type INTERVENTIONAL
Enrollment 1,280 participants
Start Date 2025-10-24
Primary Completion 2026-11-30

Eligibility & Interventions

Sex All sexes
Min Age 10 Years
Max Age 14 Years
Study Type INTERVENTIONAL
Interventions
Optimized Parenting for Lifelong Health (PLH) for Parents and Teens

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,280 participants in total. It began in 2025-10-24 with a primary completion date of 2026-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to conduct a multi-country randomized waitlist controlled trial to evaluate the effectiveness, cost-effectiveness, and scalability of the optimized Parenting for Lifelong Health (PLH) for Parents and Teens program in Moldova and North Macedonia. In Phase 2 of the FLOURISH project, a factorial trial tested multiple intervention components and identified the optimized intervention package. In Phase 3, this trial will assess the implementation, outcomes, and economic impact of the optimized PLH program delivered to adolescents aged 10-14 and their caregivers. ALTERNATIVA will deliver the program in North Macedonia and the Health for Youth Association in the Republic of Moldova.

Eligibility Criteria

Inclusion Criteria: * For Caregivers: Must be 18 years or older at baseline assessment Must be the primary caregiver of an adolescent aged 10-14 who has resided in the same household for at least four nights a week in the past month Must be able to speak at least one of the local languages in which the program will be offered (e.g., Macedonian, Romanian, Russian, Ukrainian or Albanian) Must agree to participate in the program and provide informed consent for both themselves and their adolescent For Adolescents: Must be aged 10-14 at the baseline assessment Must provide assent to participate in the study Must have caregiver consent to participate. Exclusion Criteria: * No formal exclusion criteria have been established for the FLOURISH project. However, during the study introduction, the research team will guide participants through a consent form that asks whether they are currently experiencing acute distress or a mental or physical health condition that could interfere with participation. The decision to participate will be made by the individual. If a potential participant indicates they are unable to take part due to acute health issues, the research team will provide appropriate referrals to other services.

Contact & Investigator

Central Contact

Heather M Foran, Prof

✉ heather.foran@aau.at

📞 +4346027001641

Principal Investigator

Heather M Foran, Prof

PRINCIPAL INVESTIGATOR

University of Klagenfurt

Frequently Asked Questions

Who can join the NCT07240571 clinical trial?

This trial is open to participants of all sexes, aged 10 Years or older, up to 14 Years, studying Adolescent - Emotional Problem. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07240571 currently recruiting?

Yes, NCT07240571 is actively recruiting participants. Contact the research team at heather.foran@aau.at for enrollment information.

Where is the NCT07240571 trial being conducted?

This trial is being conducted at Chisinau, Moldova, Skopje, North Macedonia.

Who is sponsoring the NCT07240571 clinical trial?

NCT07240571 is sponsored by University of Klagenfurt. The principal investigator is Heather M Foran, Prof at University of Klagenfurt. The trial plans to enroll 1,280 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology